0/100
Safety concerns found
- Ephedra extract is banned by the FDA — any amount is unsafe
- Contains proprietary blend — exact ingredient amounts not disclosed
- 18% of ingredients have research evidence
F
Label Compliance Grade
What the Evidence Says
✨ AI-generated · Qwen 3.6
· methodology
This formula contains stimulants like ephedra extract and citrus aurantium, which are studied for metabolic support, though evidence for long-term efficacy is limited. The inclusion of phenylethylamine and acacia rigidula may increase heart rate and blood pressure. Due to a low safety score, potential cardiovascular concerns and stimulant-related side effects are noted.
AI-generated summary based on research evidence. Not medical advice.
Alerts
Safety Alerts
Ephedra extract is banned by the FDA — any amount is unsafe
Contains proprietary blend — exact ingredient amounts not disclosed
✨ AI-generated · Qwen 3.6 · grounded in 2 sources
· methodology
This product received a low safety score because it contains ephedra, an ingredient banned by the FDA. Additionally, it uses a proprietary blend, meaning the exact amounts of its ingredients are not disclosed.
Details
Label Data
Other Combinations
Product Type
Ingredients
Supplement Facts — Evidence Check
Banned by FDA — any amount is unsafe
8 studies — no high-quality reviews
Market median: 983.0mg (16 products)
7 studies (A:0, B:1)
Phenylethylamine HCl
150 mg
Market median: 260.0mg (249 products)
158 studies (A:4, B:61)
Proprietary Yohimatrix
10 mg
pure White Willow bark extract
300 mg
Proprietary TriENRG
300 mg
Other Ingredients
Microcrystallline Cellulose
Dextrose
Sodium Starch Glucolate
Magnesium Stearate
Stearic Acid
Silica
FD&C Green #3
Claims
Label Claims — Verification
Unverified
All Other
Unverified
Structure/Function
Info
Product Information
Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN
Formulation Notes
27MG EPHEDRA PER DOSE
Additional Information
EXTREME FAT BURNER
MAXIMUM STRENGTH EPHEDRA WEIGHT-LOSS PRODUCT
If you have a negative reaction to this or any products contact the FDA's MedWatch at 1.800.332.1088.
Metadata
Product Details
UPC / SKU6 58059 20120 8
DSLD Entry Date2014-06-25
Product TypeOther Combinations
FormOther (e.g. tea bag)
Data Updated2026-04-11
Research
Research Evidence
B
Scopolamine (hyoscine) for preventing and treating motion sickness
Meta Analysis
The Cochrane database of systematic reviews
2011
PubMed
DOI
C
Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis
Meta Analysis
JAMA
2003
PubMed
C
Methanolic extract of Ephedra ciliata promotes wound healing and arrests inflammatory cascade in vivo through downregulation of TNF-α
Meta Analysis
Inflammopharmacology
2020
PubMed
DOI
C
Acute effect of ephedrine on 24-h energy balance
Rct
Clinical science (London, England : 1979)
1999
PubMed
C
Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects
Rct
Clinical science (London, England : 1979)
1992
PubMed
C
Hemodynamic effects of ephedra-free weight-loss supplements in humans
Rct
The American journal of medicine
2005
PubMed
D
Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure
Rct
Clinical and experimental pharmacology & physiology
2005
PubMed
D
Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers
Rct
Pharmacotherapy
2005
PubMed
D
Does ephedrine promote weight loss in low-energy-adapted obese women?
Rct
International journal of obesity
1987
PubMed
D
The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain
Rct
Clinical pharmacology and therapeutics
1996
PubMed
View all evidence for Ephedra →
This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.
